🇺🇸 FDA
Patent

US 8258122

3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives

granted A61PA61P1/00A61P1/04

Quick answer

US patent 8258122 (3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives) held by Almirall, S.A. expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/00, A61P17/00